The action ended its first day at 52.00 francs, which represents a jump of 16% compared to its reference price (44.71 francs).
The life sciences holding company Xlife Sciences started its listing on Friday on the new “Sparks” segment reserved for small and medium-sized enterprises (SMEs) of the Swiss stock exchange SIX. Requested, the title closed well above its reference price of 44.71 francs, corresponding to the closing price of 42.20 euro reached Thursday on the Munich market.
The action ended its first day on SIX at 52.00 francs, which represents a jump of 16% compared to its reference price.
The Zurich group announced in November its intention to be listed on SIX Swiss Exchange. In all, 5.20 million shares will pass to the Swiss Stock Exchange, recalled Friday Xlife Sciences in a press release. The free float will be around 45%.
The market capitalization of Xlife Sciences was 232.5 million francs considering its reference price. At closing, the valuation rose to 270 million francs.
The securities will be traded on the segment reserved for SMEs, i.e. companies whose market capitalization is less than half a billion francs. SIX launched this platform called “Sparks” in October, for which the listing procedure is simplified.